Both in Biotechnology
Champions Oncology vs Atara Biotherapeutics
Over the past year CSBR returned −27.6% and ATRA returned −43.1%; their daily moves had a correlation of 0.06.
CSBR −27.6% ATRA −43.1%Growth of $1, one year, split-adjusted
| Metric | CSBR | ATRA |
|---|---|---|
| Price | $4.92 | $8.66 |
| Market cap | $68.5M | $86.9M |
| Today | +1.86% | +4.34% |
| 1 month | +2.7% | +7.6% |
| 6 months | −15.9% | +88.3% |
| Year to date | −28.8% | −52.1% |
| 1 year | — | −44.5% |
| Revenue growth (YoY) | +8.8% | −96.4% |
| Gross margin | 50.5% | 69.7% |
| Net margin | −2.8% | −767.3% |
| P/E (TTM) | — | — |
| Price / sales | 1.1× | 14.0× |
| Net cash | $4.4M | $9.9M |
| Dividend yield | — | — |
| Volatility (60d) | 35.8% | 63.6% |
| Short % of float | 1.5% | 11.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).